Puerarin, a selective oestrogen receptor modulator, disrupts pregnancy in rats at pre-implantation stage

Reproduction

Volumn 144, Issue 5, 2012, Pages 633-645

  Saha, Piyali ^a   Saraswat, Ghungroo ^a   Chakraborty, Pratip ^b   Banerjee, Sayani ^a   Pal, Bikas C ^a   Kabir, Syed N ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Institute of Reproductive Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LEUKEMIA INHIBITORY FACTOR; PROGESTERONE; PUERARIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; EPITHELIUM; ESTRADIOL BLOOD LEVEL; FEMALE; INNER CELL MASS; NONHUMAN; PILOT STUDY; PREGNANCY DISORDER; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION;

ANIMALS; CONTRACEPTIVES, POSTCOITAL; CYCLOOXYGENASE 2; EMBRYO IMPLANTATION; ENDOMETRIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; ISOFLAVONES; LEUKEMIA INHIBITORY FACTOR; PREGNANCY; PROGESTERONE; RATS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TIME FACTORS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; PUERARIA TUBEROSA; RATTUS;

EID: 84868361302     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-11-0423     Document Type: Article

References (54)

1. Achache H & Revel A 2006 Endometrial receptivity markers, the journey to successful embryo implantation. Human Reproduction Update 12 731-746. (doi:10.1093/humupd/dml004)
2. Ahrendt HJ, Adolf D & Buhling KJ 2010 Advantages and challenges of oestrogen-free hormonal contraception. Current Medical Research and Opinion 26 1947-1955. (doi:10.1185/03007995.2010.493088)
3. Bitto A, Altavilla D, Bonaiuto A, Francesca P, Minutoli L, Stefano VD, Giuliani D, Guarini S, Arcoraci V & Squadrito F 2009 Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. Journal of Endocrinology 200 367-376. (doi:10.1677/JOE-08- 0206)
4. Boue ST, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, Shih BY, McLachlan JA & Cleveland TE 2003 Evaluation of the oestrogenic effects of legume extracts containing phyto-oestrogens. Journal of Agricultural and Food Chemistry 51 2193-2199. (doi:10.1021/ jf021114s)
5. Cai LQ, Cao YJ & Duan EK 2000 Effects of leukaemia inhibitory factor on embryo implantation in the mouse. Cytokine 12 1676-1682. (doi:10. 1006/cyto.2000.0758)
6. Cassidy A 2003 Potential risks and benefits of phyto-oestrogen-rich diets. International Journal for Vitamin and Nutrition Research 73 120-126. (doi:10.1024/0300-9831.73.2.120)
7. Chakraborty I, Das SK, Wang J & Dey SK 1996 Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the periimplantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. Journal of Molecular Endocrinology 16 107-122. (doi:10.1677/jme.0. 0160107)
8. Chung HJ, Chung MJ, Houng SJ, Jeun J, Kweon DK, Choi CH, Park JT, Park KH & Lee SJ 2009 Toxicological evaluation of the isoflavone puerarin and its glycosides. European Food Research and Technology 230 145-153. (doi:10.1007/s00217-009-1156-3)
9. Cravotto G, Boffa L, Genzini L & Garella D 2010 Phytotherapeutics: an evaluation of the potential of 1000 plants. Journal of Clinical Pharmacy and Therapeutics 35 11-48. (doi:10.1111/j.1365-2710.2009. 01096.x)
10. Cullwell KR & Curtis KM 2009 Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review. Contraception 80 337-345. (doi:10.1016/j.contraception.2009. 04.008)
11. Dey SK 1996 Implantation. In Reproductive Endocrinology, Surgery, and Technology, vol 1, pp 421-434. Eds EY Adashi, JA Rock & Z Rosenwaks. Philadelphia: Lippincott-Raven.
12. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T & Wang H 2004 Molecular cues to implantation. Endocrine Reviews 25 341-373. (doi:10.1210/er.2003-0020)
13. Farrar SC, Yenari J & Gherman RB 2003 Emergency contraception: a "fire extinguisher" for unintended pregnancies. Primary Care Update for OB/GYNS 10 284-287. (doi:10.1016/S1068-607X(03) 0069-6)
14. Hamatani T, Daikoku T, Wang H, Matsumoto H, Carter MG & Ko MSH 2004 Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. PNAS 101 10326-10331. (doi:10.1073/pnas. 0402597101)
15. Hiremath SP, Badami S, Hunasagatta SK & Patil B 2000 Antifertility and hormonal properties of the flavones of Striga orobanchoides. European Journal of Pharmacology 391 193-197. (doi:10.1016/S0014-2999 (99) 0723-2)
16. Hou X, Tan Y, Li M, Dey SK & Das SK 2004 Canonical wnt signalling is critical to oestrogen-mediated uterine growth. Molecular Endocrinology 18 3035-3049. (doi:10.1210/me.2004-0259)
17. Hwang YP & Jeong HG 2008 Mechanism of phyto-oestrogen puerarinmediated cytoprotection following oxidative injury: oestrogen receptordependent up-regulation of PI3K/Akt and HO-1. Toxicology and Applied Pharmacology 233 371-381. (doi:10.1016/j.taap.2008.09.006)
18. Jordan VC 2007 Chemoprevention of breast cancer with selective ooestrogen-receptor modulators. Nature Reviews. Cancer 7 46-53. (doi:10.1038/nrc2048)
19. Kahlenborn C, Stanford JB & Larimore WL 2002 Postfertilization effect of hormonal emergency contraception. Annals of Pharmacotherapy 36 465-470. (doi:10.1345/aph.1A344)
20. Keyes PL & Wiltbank MC 1988 Endocrine regulation of the corpus luteum. Annual Review of Physiology 50 465-482. (doi:10.1146/annurev.ph.50. 030188.002341)
21. Kinjo JE, Furusawa JL, Baba J, Eakeshita T, Yamaski M & Nohara T 1987 Studies on the constituents of Pueraria lobata III isoflavonoids and related compounds in the roots and the voluble stems. Chemical and Pharmacoceutical Bulletin 35 4846-4850. (doi:10.1248/cpb.35.4846)
22. Kuiper GG, Lemmen JG, Carlsson BO, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson J 1998 Interaction of ooestrogenic chemicals and phyto-oestrogens with oestrogen receptor b. Endocrinology 139 4252-4263. (doi:10.1210/en.139.10.4252)
23. Liu XJ, Jia Q, Wang CY & Wang NL 2009 Study on absorption mechanism of puerarin and its nanoparticles across Caco-2 cell model. Journal of Chinese Medicinal Materials 32 1252-1255.
24. Ma W, Song H, Das SK, Paria BC & Dey SK 2003 Oestrogen is a critical determinant that species the duration of the window of uterine receptivity for implantation. PNAS 100 2963-2968. (doi:10.1073/pnas. 0530162100)
25. Marino M & Galluzzo P 2008 Oestrogen receptor b mediates the protective effects of oestrogen in colon cancer. Cancer Therapy 6 149-162.
26. Matsumoto H, Ma W, Daikoku T, Zhao X, Paria BC, Das SK, Trzaskos JM & Dey SK 2002 Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. Journal of Biological Chemistry 277 29260-29267. (doi:10.1074/jbc.M203996200)
27. McCracken JA, Custer EE & Lamsa JC 1999 Luteolysis: a neuroendocrinemediated event. Physiological Reviews 79 263-323.
28. Mendez MN 2002 Emergency contraception: a review of current oral options.Western Journal of Medicine 176 188-191. (doi:10.1136/ewjm. 176.3.188)
29. Mersereau JE, Levy N, Staub RE, Baggett S, Zogric T, Chow S, Ricke WA, Tagliaferri M, Cohen I, Bjeldanes LF et al. 2008 Liquiritigenin is a plantderived highly selective oestrogen receptor b agonist. Molecular and Cellular Endocrinology 283 49-57. (doi:10.1016/j.mce.2007.11.020)
30. Minorics R, Ducza E, Marki A, Paldy E & Falkay G 2004 Investigation of oestrogen receptor a and b mRNA expression in the pregnant rat uterus. Molecular Reproduction and Development 68 463-468. (doi:10.1002/ mrd.20106)
31. Misrahi M, Loosfelt H, Atger M, Meriel C, Zerah V, Dessen P & Milgrom E 1988 Organisation of the entite rabbit progesterone receptor mRNA and of the promoter and 50 flanking region of the gene. Nucleic Acids Research 16 5459-5472. (doi:10.1093/nar/16.12.5459)
32. Murata T & Higuchi T 2003 Progesterone receptor mRNA levels during pregnancy, labor, lactation and the estrous cycle in the rat uterus. Journal of Reproduction and Development 49 425-432. (doi:10.1262/ jrd.49.425)
33. Murata T, Narita K, Honda K, Matsukawa S & Higuchi T 2003 Differential regulation of oestrogen receptor alpha and beta mRNAs in the rat uterus during pregnancy and labor: possible involvement of oestrogen receptors in oxytocin receptor regulation. Endocrine Journal 50 579-587. (doi:10. 1507/endocrj.50.579)
34. Nilsson J & Ljungkvist I 1974 Blastocyst-endometrial contact and pontamine blue reaction during normal implantation. Journal of Endocrinology 60 149-154. (doi:10.1677/joe.0.0600149)
35. Prata N 2009 Making family planning accessible in resource-poor settings. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 364 3093-3099. (doi:10.1098/rstb.2009.0172)
36. Psychoyos A 1973 Hormonal control of ovoimplantation. Vitamins and Hormones 31 201-256. (doi:10.1016/S0083-6729(08) 0999-1)
37. Psychoyos A 1984 Uterine sensitivity for blastocyst implantation. Journal of Biosciences 6 7-10. (doi:10.1007/BF02716711)
38. Psychoyos A, Nikas G & Gravanis A 1995 The role of prostaglandins in blastocyst implantation. Human Reproduction 10 30-42. (doi:10.1093/ humrep/10.suppl-2.30)
39. Sahlin L, Masironi B, Akerberg S & Eriksson H 2006 Tissue- and hormonedependent progesterone receptor distribution in the rat uterus. Reproductive Biology and Endocrinology 4 1-11. (doi:10.1186/1477- 7827-4-47)
40. Sander PM, Raymond EG & Weaver MA 2009 Emergency contraceptive use as a marker of future risky sex, pregnancy and sexually transmitted infection. American Journal of Obstetrics and Gynecology 201 146.e1-146.e6. (doi:10.1016/j.ajog.2009.05.015)
41. Sengupta J, Paria BC & Manchanda SK 1983 Steroid hormones and embryo development in ovariectomized hamsters. Journal of Reproduction and Fertility 67 369-372. (doi:10.1530/jrf.0.0670369)
42. Shukla S 1996 Post-coital contraceptive action of Pueraria tuberosa DC. extract in rats. Phytotherapy Research 10 95-99. (doi:10.1002/ (SICI) 099-1573(199603) 0:2!95::AID-PTR699O3.0.CO;2-5)
43. Shukla S & Mathur R 2002 Purareia tuberosa DC: contraceptive efficacy and toxicological profile. In Pueraria: the Genus Pueraria, 1st edn, pp 85-97. Eds Keung MW. New York: Taylor and Francis, Inc.
44. Simon C, Dominguez F, Valbuena D & Pellicer A 2003 The role of oestrogen in uterine receptivity and blastocyst implantation. Trends in Endocrinology and Metabolism 14 197-199. (doi:10.1016/S1043- 2760(03) 0084-5)
45. Song H, Lim H, Das SK, Paria BC & Dey SK 2000 Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Molecular Endocrinology 14 1147-1161. (doi:10.1210/me.14.8. 1147)
46. Sylvestre M, Pichette A, Longtin A, Nagau F & Legault J 2006 Essential oil analysis and anticancer activity of leaf essential oil of Croton flavens L. from Guadeloupe. Journal of Ethnopharmacology 103 99-102. (doi:10. 1016/j.jep.2005.07.011)
47. Tabibzadeh S 1998 Molecular control of the implantation window. Human Reproduction Update 4 465-471. (doi:10.1093/humupd/4.5.465)
48. Terkel J 1988 Neuroendocrine processes in the establishment of pregnancy and pseudopregnancy in rats. Psychoneuroendocrinology 13 5-28. (doi:10.1016/0306-4530(88) 0004-2)
49. Wang H & Dey SK 2006 Roadmap to embryo implantation: clues from mouse models. Nature Genetics 7 185-199. (doi:10.1038/nrg1808)
50. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggit D, Koblar SA, Gliniak BC, McKena HJ, Papayannopoulou T, Thoma B et al. 1995 Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121 1283-1299.
51. White CA, Zhang JG, Salamonsen LA, Baca M, Fairlie WD & Metcalf D 2007 Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy. PNAS 104 19357-19362. (doi:10.1073/pnas.0710110104)
52. Wu H, Lu C, Zhou A, Min Z & Zhang Y 2009 Enhanced oral bioavailability of puerarin using microemulsion vehicle. Drug Development and Industrial Pharmacy 35 138-144. (doi:10.1080/03639040801973495)
53. Wuttke W, Jarry H & Seidlova-Wuttke D 2010 Definition, classification and mechanism of action of endocrine disrupting chemicals. Hormones 9 9-15.
54. Zheng G, Zhang X, Zheng J, Meng Q & Zheng D 2002 Oestrogen-like effects of puerarin and total isoflavones from Pueraria lobata. Journal of Chinese Medicinal Materials 25 566-568.